Cyprus Mail

€192 million investment in Aphrodite announced

comment ellinas between the aphrodite and glafkos fields, cyprus has over 300bcm gas
The reality is that the Republic is in negotiations with an energy giant, which would suggest this is an unequal contest

Oil companies operating the Aphrodite gas field have approved a €192 million investment to start drilling, Israeli company NewMed said on Sunday.

The amount will also cover other development costs for the project in Cyprus’ Excusive Economic Zone (EEZ).

The drill, expected to start in the first six months of 2023, will confirm how much gas is in the field, which has been estimated at 124 billion cubic metres, NewMed said.

NewMed has a 30 per cent share in the Aphrodite field, which is located about 170km south of Limassol in Block 12. The remainder of the share is equally split between Chevron and Shell.

The partners are examining development options, NewMed said, including connecting the field to existing facilities in the area or linking it to development plans for nearby assets in Egypt, Reuters reported.

Israeli energy minister Karine Elharrar will be in Cyprus on Monday to address the ongoing dispute with Nicosia over the Yishai and Aphrodite gas fields, her Cypriot counterpart Natasa Pilides said.

Reportedly, Elharrar will propose to the Cypriot side to take over 10 per cent of the field which the Israeli side considers its own, against monetary compensation.

This comes six months after intergovernmental parleys aimed at resolving the longstanding dispute were announced to be taking place between the two countries.

Follow the Cyprus Mail on Google News

Related Posts

Putin, flanked by Russian fighters, jets into Middle East to talk oil

Reuters News Service

Cypriot children perform well below average in maths, reading and science

Tom Cleaver

Free mouth cancer examinations this week

Staff Reporter

Cyprus tops EU list for taking antibiotics

Nikolaos Prakas

Only half of Cypriots intend to vote in EU elections

Tom Cleaver

Okypy: Nicosia General’s accredited clinical labs specialised in rare, serious cases

CM Guest Columnist